Figure 3.
Nonrelapse mortality, incidence of relapse, and survival. The estimates of the cumulative incidence of death from causes other than relapse or progression (A) and the incidence of relapsing disease (B). With a median follow-up of 18 months (range, 13-27 months), the Kaplan-Meier estimates of overall survival (C) and relapse-free survival (D) are depicted.